BioCentury | Sep 16, 2013
Clinical News

Cf-BRAF: Clinical trial start

Next quarter, Trovagene said researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS , cf-BRAF and cf-PIK3CA molecular diagnostic assays to monitor therapy response in <100 mCRC patients. Trovagene...
BioCentury | Sep 16, 2013
Clinical News

Cf-KRAS: Clinical trial start

Next quarter, Trovagene said researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS, cf-BRAF and cf-PIK3CA molecular diagnostic assays to monitor therapy response in <100 mCRC patients. Trovagene...
BioCentury | Sep 16, 2013
Clinical News

Cf-PIK3CA: Clinical trial start

Next quarter, Trovagene said researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS , cf-BRAF and cf-PIK3CA molecular diagnostic assays to monitor therapy response in <100 mCRC patients. Trovagene...
Items per page:
1 - 3 of 3